Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Gilead Sciences Inc., consolidated statement of comprehensive income

US$ in millions

12 months ended:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	5,613)	4,566)	6,201)	89)	5,364)
Net foreign currency translation gain (loss)	60)	(11)	(38)	(2)	6)
Net unrealized gain (loss), net of tax	26)	(30)	(6)	43)	54)
Reclassifications to net income, net of tax	2)	1)	—)	(42)	(1)
Available-for-sale debt securities, net change	28)	(29)	(6)	1)	53)
Net unrealized gain (loss), net of tax	(12)	130)	129)	(103)	72)
Reclassifications to net income, net of tax	(50)	(171)	58)	(41)	(126)
Cash flow hedges, net change	(62)	(41)	187)	(144)	(54)
Other comprehensive income (loss), net	26)	(81)	143)	(145)	5)
Comprehensive income (loss), net	5,639)	4,485)	6,344)	(56)	5,369)
Comprehensive loss attributable to noncontrolling interest, net	52)	26)	24)	34)	22)
Comprehensive income (loss) attributable to Gilead, net	5,691)	4,511)	6,368)	(22)	5,391)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Download chart

Comprehensive income item	Description	The company
Net income attributable to Gilead	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Gilead Sciences Inc. net income attributable to Gilead decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.
Comprehensive income (loss) attributable to Gilead, net	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners.	Gilead Sciences Inc. comprehensive income (loss) attributable to Gilead, net decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.

Gilead Sciences Inc. (NASDAQ:GILD)

Statement of Comprehensive Income